Surgical Innovations Group plc provided earnings guidance for the full year ending December 31, 2014. For the period, the board expects that the company will report a significant loss before tax. Against this backdrop, short-term working capital funding and cash generation remains the board's key priority and further updates will be provided to shareholders as appropriate.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.425 GBX | 0.00% |
|
-5.56% | -29.17% |
Jun. 10 | Surgical Innovations names Weir's Chris Martin as CFO | AN |
Jun. 10 | Surgical Innovations Group Appoints CFO | MT |
![Consensus](/images/consensus_flch.gif)
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.17% | 5.03M | |
-4.26% | 185B | |
-1.64% | 105B | |
-2.28% | 68.9B | |
+15.79% | 46.41B | |
-6.58% | 46.16B | |
+5.36% | 40.75B | |
+20.50% | 31.11B | |
+11.60% | 24.26B | |
-6.51% | 23.94B |
- Stock Market
- Equities
- SUN Stock
- News Surgical Innovations Group plc
- Surgical Innovations Group plc Provides Earnings Guidance for the Full Year Ending December 31, 2014